[ad_1]
THE WHAT? Beiersdorf has introduced that it has bought a majority stake in Belgian life science agency, S-Biomedic. The German proprietor of Nivea has invested within the pores and skin microbiome specialist beforehand as a part of its company enterprise capital actions. The acquisition worth was not disclosed.
THE DETAILS The collaboration between the 2 firms will turn out to be nearer following the cope with S-Biomedic managed as a standalone entity underneath Beiersdorf’s present microbiome program.
THE WHY? Dr Gitta Neufang, Senior Vice President of Analysis & Growth at Beiersdorf, explains, “As skincare consultants, analysis has been on the coronary heart of what we’ve been doing for 140 years. Subsequently, the acquisition of S-Biomedic is a perfect strategic match to drive our innovation energy even additional consistent with our C.A.R.E.+ technique. Along with the pioneers of S-Biomedic we’re taking skincare to the subsequent stage and can foster the event of options for unmet shopper wants.”
[ad_2]
Source_link
